Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2004

De Cecco L, Marchionni L, Gariboldi M, Reid JF, M Lagonigro S, Caramuta S, et al. Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2. Oncogene. 2004;23(49):8171-83.

2003

Kahana DD, Cass O, Jessurun J, Schwarzenberg SJ, Sharp H, Khan K. Sclerosing cholangitis associated with trichosporon infection and natural killer cell deficiency in an 8-year-old girl:. J Pediatr Gastroenterol Nutr. 2003;37(5):620-3.

Cannon M, Philpott NJ, Cesarman E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol. 2003;77(1):57-67.

Magro CM, Klinger DM, Adams PW, Orosz CG, Pope-Harman AL, W Waldman J, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003;3(10):1264-72.

Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematol Oncol Clin North Am. 2003;17(3):717-45.

Garcia-Cao I, Lafuente MJ, Criado LM, Diaz-Meco MT, Serrano M, Moscat J. Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38. EMBO Rep. 2003;4(3):307-12.

Allen EA, Parwani AV, Siddiqui MT, Clark DP, Ali SZ. Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol. 2003;47(2):183-7.

Chadburn A, Narayanan S. Lymphoid malignancies: immunophenotypic analysis. Adv Clin Chem. 2003;37:293-353.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, et al. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21(16):3051-9.

Barbareschi M, Murer B, Colby TV, Chilosi M, Macrì E, Loda M, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 2003;27(2):141-9.